MYOCARDIAL BLOOD FLOW RESERVE: A BIOMARKER FOR ADVERSE CARDIOVASCULAR OUTCOMES?  by Anjan, Venkatesh et al.
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
A1146
JACC March 17, 2015
Volume 65, Issue 10S
mYocArdiAl Blood floW reserve: A BiomArker for Adverse cArdiovAsculAr 
outcomes?
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Cardiac PET Imaging
Abstract Category: 19.  Non Invasive Imaging: Nuclear
Presentation Number: 1135-011
Authors: Venkatesh Anjan, Daniel Pryma, Payman Zamani, Marie Guerraty, Jacob Dubroff, University of Pennsylvania, Philadelphia, PA, 
USA
Background:  Quantification of myocardial blood flow reserve (MBFR) using myocardial positron emission tomography (PET) perfusion 
imaging has previously been validated in scientific studies as a biomarker for ischemia. However, some studies report variability in coronary 
flow reserve thresholds for ischemia and adverse clinical events. We hypothesized that patients undergoing PET perfusion with a reduced 
global MBFR would have worse cardiovascular outcomes.
methods:  This was a single center retrospective study of consecutive patients who underwent dipyridamole Rubidium-82 stress/rest 
myocardial perfusion PET/computed tomography (CT) between March 2012 and March 2013; all studies were performed on a Siemens 
Biograph mCT PET/CT system using syngo MBF software, which provided quantitative rest and stress flows, and MBFR. Perfusion 
was dichotomized as normal versus abnormal based on the presence of perfusion defects. All patients were followed for one year. The 
primary end point was a composite of major adverse cardiovascular events (MACE), which included: all cause mortality, acute coronary 
syndrome (ST segment elevation myocardial infarction (MI), non-ST segment elevation MI, or unstable angina) and revascularization by 
either percutaneous coronary intervention or coronary artery bypass surgery. Logistic regression models were created with MACE as the 
dependent variable. Adjustment for perfusion status (normal versus abnormal) was performed.
results:  This study included 179 patients out of which14 patients (7.8%) had MACE. Patients with MACE demonstrated significantly 
depressed mean global MBFR compared to controls (1.6±0.6 versus 2.2±0.7, p = 0.004). Patients with any qualitative abnormal perfusion 
defect had an increased risk of MACE (OR 2.9, 95%CI 1.0-8.3, p = 0.05). Global MBFR was lower in cases versus controls, after adjusting 
for perfusion status (Mean global reserve in cases 1.7 [95% CI 1.4-2.1] versus controls 2.1 [95% CI 2.0-2.3], P=0.04).
conclusion:  Patients with MACE had lower global MBFR even after adjustment for perfusion status. Our data suggest that global reserve 
is more associated with adverse outcomes than qualitative perfusion status.
